Aytu BioPharma (LTS:0A8M) Total Stockholders Equity : $29.83 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aytu BioPharma Total Stockholders Equity?

Aytu BioPharma's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $29.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Aytu BioPharma's Book Value per Share for the quarter that ended in Sep. 2024 was $4.85. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Aytu BioPharma's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.56.

Aytu BioPharma Total Stockholders Equity Historical Data

The historical data trend for Aytu BioPharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma Total Stockholders Equity Chart

Aytu BioPharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Stockholders Equity

Get a 7-Day Free Trial

95.02

137.57

44.31

39.36

27.72

Aytu BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															32.17	32.85	30.78	27.72	29.83

Aytu BioPharma (LTS:0A8M) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Aytu BioPharma's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(29.826	-	0)	/	6.1492
	=	4.85

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Aytu BioPharma's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.127	+	10.43)	/	29.826
	=	0.56

Aytu BioPharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Aytu BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (LTS:0A8M) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

AYTU:USA

Address

7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237

Website

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Aytu BioPharma Headlines

No Headlines